ARTICLE | Clinical News
Human heterologous liver cells: Phase II started
April 25, 2011 7:00 AM UTC
Cytonet began the open-label, U.S. Phase II SELICA III trial to evaluate infusions of human heterologous liver cells in 20 infant and pediatric patients. ...